Pulse lineResearch With Heart Logo

ARIC Publications

Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kytömaa S, Hegde S, Claggett B, et al. "Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study." JAMA Cardiol. 2019;4(4):363-369.
Kwon Y, Norby FL, Jensen PN, et al. "Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS)." PLoS One. 2016;11(1):e0147065.
Kunkle BW, Grenier-Boley B, Sims R, et al. "Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing." Nat Genet. 2019;51(3):414-430.
Kummer AE, Grams M, Lutsey PL, et al. "Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study." Clin J Am Soc Nephrol. 2015;10(11):2023-9.
Kulkarni M, Foraker RE, McNeill AM, et al. "Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants." Diabetes Obes Metab. 2017;19(9):1260-1266.
Kucharska-Newton AM, Monda KL, Bielinski SJ, et al. "Role of BMI in the Association of the TCF7L2 rs7903146 Variant with Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study." J Obes. 2010;2010.
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study." Acta Diabetol. 2010;47 Suppl 1:161-8.
Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR. "HDL-cholesterol and incidence of breast cancer in the ARIC cohort study." Ann Epidemiol. 2008;18(9):671-7.
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort." Arterioscler Thromb Vasc Biol. 2009;29(12):2182-90.
Kucharska-Newton AM, Monda KL, Campbell S, et al. "Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2011;216(1):151-6.
Kucharska-Newton AMaria, Palta P, Burgard S, et al. "Operationalizing Frailty in the Atherosclerosis Risk in Communities Study Cohort." J Gerontol A Biol Sci Med Sci. 2017;72(3):382-388.
Kucharska-Newton AM, Rosamond WD, Schroeder JC, McNeill A M, Coresh J, Folsom AR. "HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study." Lung Cancer. 2008;61(3):292-300.
Kucharska-Newton AMaria, Heiss G, Ni H, Stearns SC, Puccinelli-Ortega N, Wruck LM. "Identification of Heart Failure Events in Medicare Claims: The Atherosclerosis Risk in Communities (ARIC) Study." J Card Fail. 2016;22(1):48-55.
Kucharska-Newton AMaria, Williams JE, Chang PP, Stearns SC, Sueta CA, Blecker SB. "Anger proneness, gender, and the risk of heart failure." J Card Fail. 2014;20(12):1020-6.
Kucharska-Newton AM, Harald K, Rosamond WD, Rose KM, Rea TD, Salomaa V. "Socioeconomic indicators and the risk of acute coronary heart disease events: comparison of population-based data from the United States and Finland." Ann Epidemiol. 2011;21(8):572-9.
Kucharska-Newton AMaria, Griswold M, Yao ZHoward, et al. "Cardiovascular Disease and Patterns of Change in Functional Status Over 15 Years: Findings From the Atherosclerosis Risk in Communities (ARIC) Study." J Am Heart Assoc. 2017;6(3).
Kubota Y, Alonso A. "β-Thromboglobulin and incident cardiovascular disease risk: The Atherosclerosis Risk in Communities study." Thromb Res. 2017;155:116-120.
Kubota Y, Chen LYee, Whitsel EA. "Heart rate variability and lifetime risk of cardiovascular disease: the Atherosclerosis Risk in Communities Study." Ann Epidemiol. 2017;27(10):619-625.e2.
Kubota Y, London SJ, Cushman M, et al. "Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study." J Thromb Haemost. 2016;14(12):2394-2401.
Kubota Y, Cushman M, Zakai N, Rosamond WD. "TV viewing and incident venous thromboembolism: the Atherosclerotic Risk in Communities Study." J Thromb Thrombolysis. 2018;45(3):353-359.
Kubota Y, Alonso A, Shah AM, Chen LYee. "Television Watching as Sedentary Behavior and Atrial Fibrillation: The Atherosclerosis Risk in Communities Study." J Phys Act Health. 2018;15(12):895-899.
Kubota Y, McAdams-DeMarco M. "Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study." Thromb Res. 2016;144:144-8.
Kubota Y, Evenson KR, Maclehose RF, Roetker NS, Joshu CE. "Physical Activity and Lifetime Risk of Cardiovascular Disease and Cancer." Med Sci Sports Exerc. 2017;49(8):1599-1605.
Kubota Y, Folsom AR, Pankow JS, Wagenknecht LE. "Diabetes-related factors and abdominal aortic aneurysm events: the Atherosclerotic Risk in Communities Study." Ann Epidemiol. 2018;28(2):102-106.e1.
Kubota Y, Folsom AR, Ballantyne CM. "Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study." Atherosclerosis. 2018;268:63-67.
Kubota Y, Heiss G, Maclehose RF, Roetker NS. "Association of Educational Attainment With Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study." JAMA Intern Med. 2017;177(8):1165-1172.
Kubota Y, Alonso A, Heckbert SR, Norby FL. "Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis." Heart Lung Circ. 2019;28(4):615-622.
Kubota Y, Folsom AR, Matsushita K, Couper DJ. "Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study." Atherosclerosis. 2018;268:225-230.
Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. "Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease." Am J Med. 2006;119(2):133-41.
Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, Falk RJ. "Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study." Am J Kidney Dis. 2005;45(4):650-7.
Kshirsagar AV, Offenbacher S, Moss KL, Barros SP, Beck JD. "Antibodies to periodontal organisms are associated with decreased kidney function. The Dental Atherosclerosis Risk In Communities study." Blood Purif. 2007;25(1):125-32.
Kshirsagar AV, Coresh J, Brancati F, Colindres RE. "Ankle brachial index independently predicts early kidney disease." Ren Fail. 2004;26(4):433-43.
Krop JS, Coresh J, Chambless LE, et al. "A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study." Arch Intern Med. 1999;159(15):1777-83.
Kritchevsky SB, Tell GS, Shimakawa T, et al. "Provitamin A carotenoid intake and carotid artery plaques: the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 1998;68(3):726-33.
Kritchevsky SB, Shimakawa T, Tell GS, et al. "Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Atherosclerosis Risk in Communities Study." Circulation. 1995;92(8):2142-50.
Krishnappa D, Wang W, Rooney MR, et al. "Life's Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study." Int J Cardiol. 2021.
Krishnan S, Steffen LM, Paton CM. "Impact of dietary fat composition on prediabetes: a 12-year follow-up study." Public Health Nutr. 2017;20(9):1617-1626.
Kraja AT, Vaidya D, Pankow JS, et al. "A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium." Diabetes. 2011;60(4):1329-39.
Kraja AT, Cook JP, Warren HR, et al. "New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals." Circ Cardiovasc Genet. 2017;10(5).
Kraja AT, Liu C, Fetterman JL, et al. "Associations of Mitochondrial and Nuclear Mitochondrial Variants and Genes with Seven Metabolic Traits." Am J Hum Genet. 2019;104(1):112-138.
Kraja AT, Chasman DI, North KE, et al. "Pleiotropic genes for metabolic syndrome and inflammation." Mol Genet Metab. 2014;112(4):317-38.
Kowalski MH, Qian H, Hou Z, et al. "Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations." PLoS Genet. 2019;15(12):e1008500.
Kovesdy CP, Coresh JJ, Ballew SH, et al. "Past Decline Versus Current eGFR and Subsequent ESRD Risk." J Am Soc Nephrol. 2016;27(8):2447-55.
Kou M, Ding N, Ballew SH, et al. "Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease." Arterioscler Thromb Vasc Biol. 2021;41(3):1229-1238.
Köttgen A, Albrecht E, Teumer A, et al. "Genome-wide association analyses identify 18 new loci associated with serum urate concentrations." Nat Genet. 2013;45(2):145-54.
Köttgen A, Hsu CC, Coresh J, et al. "The association of podocin R229Q polymorphism with increased albuminuria or reduced estimated GFR in a large population-based sample of US adults." Am J Kidney Dis. 2008;52(5):868-75.
Köttgen A, Hwang S-J, Rampersaud E, et al. "TCF7L2 variants associate with CKD progression and renal function in population-based cohorts." J Am Soc Nephrol. 2008;19(10):1989-99.
Köttgen A, Pattaro C, Böger CA, et al. "New loci associated with kidney function and chronic kidney disease." Nat Genet. 2010;42(5):376-84.
Köttgen A, Yang Q, Shimmin LC, et al. "Association of estimated glomerular filtration rate and urinary uromodulin concentrations with rare variants identified by UMOD gene region sequencing." PLoS One. 2012;7(5):e38311.
Köttgen A, Glazer NL, Dehghan A, et al. "Multiple loci associated with indices of renal function and chronic kidney disease." Nat Genet. 2009;41(6):712-7.
Köttgen A, Russell SD, Loehr LR, et al. "Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study." J Am Soc Nephrol. 2007;18(4):1307-15.
Köttgen A, Kao W HL, Hwang S-J, et al. "Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies." BMC Med Genet. 2008;9:49.
Köttgen A, Hwang S-J, Larson MG, et al. "Uromodulin levels associate with a common UMOD variant and risk for incident CKD." J Am Soc Nephrol. 2010;21(2):337-44.
Koton S, Schneider ALC, B Windham G, Mosley TH, Gottesman RF. "Microvascular Brain Disease Progression and Risk of Stroke: The ARIC Study." Stroke. 2020;51(11):3264-3270.
Koton S, Schneider ALC, Rosamond WD, Shahar E, Sang Y, Gottesman RF. "Stroke incidence and mortality trends in US communities, 1987 to 2011." JAMA. 2014;312(3):259-68.
Koton S, Wruck L, Quibrera PMiguel, et al. "Temporal trends in validated ischaemic stroke hospitalizations in the USA." Int J Epidemiol. 2019;48(3):994-1003.
Koton S, Sang Y, Schneider ALC, Rosamond WD, Gottesman RF. "Trends in Stroke Incidence Rates in Older US Adults: An Update From the Atherosclerosis Risk in Communities (ARIC) Cohort Study." JAMA Neurol. 2020;77(1):109-113.
Kors JA, Crow RS, Hannan PJ, Rautaharju PM, Folsom AR. "Comparison of computer-assigned Minnesota Codes with the visual standard method for new coronary heart disease events." Am J Epidemiol. 2000;151(8):790-7.
Korada SKrishna C, Zhao D, Gottesman RF, et al. "Parathyroid Hormone and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study." J Stroke Cerebrovasc Dis. 2016;25(4):883-93.
Kong L, Cai J. "Case-cohort analysis with accelerated failure time model." Biometrics. 2009;65(1):135-42.
Konety S, Koene RJ, Norby FL, et al. "Echocardiographic Predictors of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study and Cardiovascular Health Study." Circ Cardiovasc Imaging. 2016;9(8).
Kohsaka S, Volcik KA, Folsom AR, et al. "Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study." Atherosclerosis. 2008;196(2):926-30.
Koene RJ, M Alraies C, Norby FL, et al. "Relation of the CHADS-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study)." Am J Cardiol. 2019;123(3):402-408.
Kocarnik JM, Richard M, Graff M, et al. "Discovery, fine-mapping, and conditional analyses of genetic variants associated with C-reactive protein in multiethnic populations using the Metabochip in the Population Architecture using Genomics and Epidemiology (PAGE) study." Hum Mol Genet. 2018;27(16):2940-2953.
Kocarnik JM, Pendergrass SA, Carty CL, et al. "Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study." Circ Cardiovasc Genet. 2014;7(2):178-88.
Knuiman MW, Folsom AR, Chambless LE, Liao D, Wu KK. "Association of hemostatic variables with MRI-detected cerebral abnormalities: the atherosclerosis risk in communities study." Neuroepidemiology. 2001;20(2):96-104.
Knowles JW, Assimes TL, Boerwinkle E, et al. "Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD." BMC Med Genet. 2008;9:23.
Knopman D, Boland LL, Mosley T, et al. "Cardiovascular risk factors and cognitive decline in middle-aged adults." Neurology. 2001;56(1):42-8.
Knopman DS, Penman AD, Catellier DJ, et al. "Vascular risk factors and longitudinal changes on brain MRI: the ARIC study." Neurology. 2011;76(22):1879-85.
Knopman DS, Griswold ME, Lirette ST, et al. "Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study." Stroke. 2015;46(2):433-40.
Knopman DS, Gottesman RF, Sharrett ARichey, et al. "Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)." Alzheimers Dement (Amst). 2016;2:1-11.
Knopman DS, Mosley TH, Catellier DJ, A Sharrett R. "Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort." Neurology. 2005;65(6):876-81.
Knopman DS, Gottesman RF, Sharrett ARichey, et al. "Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study." Alzheimers Dement. 2018;14(11):1406-1415.
Knopman DS, Mosley TH, Catellier DJ, Coker LH. "Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study." Alzheimers Dement. 2009;5(3):207-14.
Klos K, Shimmin L, Ballantyne C, et al. "APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels." Hum Mol Genet. 2008;17(13):2039-46.
Klimentidis YC, Arora A, Zhou J, Kittles R. "The Genetic Contribution of West-African Ancestry to Protection against Central Obesity in African-American Men but Not Women: Results from the ARIC and MESA Studies." Front Genet. 2016;7:89.
Klimentidis YC, Raichlen DA, Bea J, et al. "Genome-wide association study of habitual physical activity in over 377,000 UK Biobank participants identifies multiple variants including CADM2 and APOE." Int J Obes (Lond). 2018;42(6):1161-1176.
Klein R, A Sharrett R, Klein BEK, et al. "The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study." Ophthalmology. 2002;109(7):1225-34.
Klein R, Sharrett AR, Klein BE, et al. "Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study." Arterioscler Thromb Vasc Biol. 2000;20(6):1644-50.
Klein R, Clegg L, Cooper LS, et al. "Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study." Arch Ophthalmol. 1999;117(9):1203-10.

Pages